BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21670739)

  • 1. ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner.
    Kumar P; Agarwal R; Siddiqui I; Vora H; Das G; Sharma P
    Immunol Cell Biol; 2012 Apr; 90(4):411-20. PubMed ID: 21670739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
    Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
    J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Lipoprotein Rv1016c Derived from
    Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
    Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sengupta S; Naz S; Das I; Ahad A; Padhi A; Naik SK; Ganguli G; Pattanaik KP; Raghav SK; Nandicoori VK; Sonawane A
    J Biol Chem; 2017 Apr; 292(17):6855-6868. PubMed ID: 28209712
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
    Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
    Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
    Chou SD; Khan AN; Magner WJ; Tomasi TB
    Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Velásquez LN; Milillo MA; Delpino MV; Trotta A; Fernández P; Pozner RG; Lang R; Balboa L; Giambartolomei GH; Barrionuevo P
    J Leukoc Biol; 2017 Mar; 101(3):759-773. PubMed ID: 27765819
    [No Abstract]   [Full Text] [Related]  

  • 11. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression.
    Dong Y; Tang L; Letterio JJ; Benveniste EN
    J Immunol; 2001 Jul; 167(1):311-9. PubMed ID: 11418665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
    Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
    J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells.
    Wang Y; Curry HM; Zwilling BS; Lafuse WP
    J Immunol; 2005 May; 174(9):5687-94. PubMed ID: 15843570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.
    Yotsumoto K; Sanui T; Tanaka U; Yamato H; Alshargabi R; Shinjo T; Nakao Y; Watanabe Y; Hayashi C; Taketomi T; Fukuda T; Nishimura F
    Front Immunol; 2020; 11():709. PubMed ID: 32373130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells.
    Pazmany T; Tomasi TB
    J Neuroimmunol; 2006 Mar; 172(1-2):18-26. PubMed ID: 16360884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.